Noriko Fukuhara
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 189 publications
Decrease in PNH-type Blood Cells after the Cessation of Thrombopoietin Receptor Agonist in a Case of AA-PNH Syndrome.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.
Journal: Blood advances
Published: February 04, 2026
Successful cord blood transplantation for a unique mature γδ T-cell leukemia with KMT2A::AFDN translocation.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: January 28, 2026
The Outcomes of Single-unit Unrelated Umbilical Cord Blood Transplantation for Adult Acute Myeloid Leukemia with RUNX1::RUNX1T1 in Multicenter Retrospective analysis.
Journal: Transplantation proceedings
Published: January 23, 2026
Extramedullary blast crisis limited to the lymph nodes in chronic myeloid leukemia with a T/myeloid mixed phenotype
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 12, 2026
Heme synthesis inhibition induces the intrinsic apoptosis pathway in leukemia with OSGIN1 upregulation.
Journal: Experimental hematology
Published: January 08, 2026
Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trial.
Journal: International journal of clinical oncology
Published: January 06, 2026
Safety profiles in elderly patients with DLBCL on first-line Pola-R-CHP: a claims database study in Japan.
Journal: Leukemia & lymphoma
Published: November 03, 2025
Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.
Journal: Future oncology (London, England)
Published: October 31, 2025
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma.
Journal: International journal of clinical oncology
Published: October 29, 2025
Last Updated: 09/26/2026